Thursday, July 9, 2026

pharma · PTIX

Protagenic Therapeutics, Inc.new

Protagenic Therapeutics, Inc.new drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

NEW YORK, NY, USA HQ
1 Employees
Public company Type
PTIX · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, USA
Employees
1
Programs
1
Drugs
2
Patents
0
Intelligence · Drug Pipeline

Protagenic Therapeutics, Inc.new pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Protagenic Therapeutics, Inc.new drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Protagenic Therapeutics, Inc.new in public FDA and regional records.

  2. Development asset linked to Protagenic Therapeutics, Inc.new in public FDA and regional records.